БИОХИМИЯ, 2019, том 84, вып. 2, с. 172–190
УДК 577.25
TRPA1 канал — регулятор нейрогенного воспаления и боли: структура, функция, роль в патофизиологии, терапевтический потенциал лигандов
Обзор
1 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук, 117997 Москва, Россия; электронная почта: yaroslav.andreev@yahoo.com
2 Первый московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации, 119991 Москва, Россия
Поступила в редакцию 14.06.2018
После доработки 28.09.2018
Принята к публикации 28.09.2018
DOI: 10.1134/S0320972519020027
КЛЮЧЕВЫЕ СЛОВА: канал временного рецепторторного потенциала анкириновый, TRPA1, боль, воспаление, лиганды, низкомолекулярные модуляторы, пептиды.
Аннотация
TRPA1 представляет собой катионный канал, локализованный на плазматической мембране в чувствительных нейронах кожи, клетках эпителия кишечника, легких, мочевого пузыря и других клеток человека и животных. TRPA1 отвечает на термические и механические стимулы, а также является основным хемосенсором. Вещества, активирующие TRPA1 (именно к таким относятся AITC, определяющий острый вкус горчицы, хрена и васаби, коричный альдегид из корицы, сераорганические соединения из чеснока и лука, слезоточивый газ, акролеин и кротоновый альдегид, содержащиеся в сигаретном дыме и др.), вызывают жжение, механическую и термическую гиперчувствительность, кашель, раздражение глаз, чихание, образование слизи, а также нейрогенное воспаление. Известно, что повышенная активность TRPA1 приводит к возникновению хронического кожного зуда и аллергического дерматита, а также связана с «синдромом эпизодической боли» — наследственным заболеванием, которое характеризуется неожиданно возникающей изнурительной болью при стрессе. В медицинском аспекте TRPA1 сегодня рассматривается как одна из мишеней для создания новых противовоспалительных и обезболивающих лекарственных средств. В обзоре суммирована информация о структуре, функции и физиологической роли TRPA1 канала, описаны известные лиганды, дается анализ их практической значимости для применения в качестве терапевтических средств для лечения болевых состояний, связанных с воспалением.
Текст статьи
Сноски
* Адресат для корреспонденции.
Финансирование
Работа поддержана РНФ (грант 16-15-00167).
Конфликт интересов
Авторы заявляют об отсутствии конфликта интересов.
Соблюдение этических норм
Настоящая статья не содержит описания каких-либо исследований с использованием людей и животных в качестве объектов.
Список литературы
1. Schenker, T., and Trueb, B. (1998) Down-regulated proteins of mesenchymal tumor cells, Exp. Cell. Res., 239, 161–168.
2. Jaquemar, D., Schenker, T., and Trueb, B. (1999) An ankyrin-like protein with transmembrane domains is specifically lost after oncogenic transformation of human fibroblasts, J. Biol. Chem., 274, 7325–7333.
3. Kang, K., Pulver, S.R., Panzano, V.C., Chang, E.C., Griffith, L.C., Theobald, D.L., and Garrity, P.A. (2010) Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception, Nature, 464, 597–600.
4. Bianchi, B.R., Zhang, X.F., Reilly, R.M., Kym, P.R., Yao, B.B., and Chen, J. (2012) Species comparison and pharmacological characterization of human, monkey, rat, and mouse TRPA1 channels, J. Pharmacol. Exp. Ther., 341, 360–368.
5. Wu, L.J., Sweet, T.B., and Clapham, D.E. (2010) International union of basic and clinical pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family, Pharmacol. Rev., 62, 381–404.
6. Nilius, B., and Szallasi, A. (2014) Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine, Pharmacol. Rev., 66, 676–814.
7. Perraud, A.L., Fleig, A., Dunn, C.A., Bagley, L.A., Launay, P., Schmitz, C., Stokes, A.J., Zhu, Q., Bessman, M.J., Penner, R., Kinet, J.P., and Scharenberg, A.M. (2001) ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology, Nature, 411, 595–599.
8. Yamaguchi, H., Matsushita, M., Nairn, A.C., and Kuriyan, J. (2001) Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity, Mol. Cell, 7, 1047–1057.
9. Gaudet, R. (2008) A primer on ankyrin repeat function in TRP channels and beyond, Mol. Biosyst., 4, 372–379.
10. Liao, M., Cao, E., Julius, D., and Cheng, Y. (2013) Structure of the TRPV1 ion channel determined by electron cryo-microscopy, Nature, 504, 107–112.
11. Paulsen, C.E., Armache, J.P., Gao, Y., Cheng, Y., and Julius, D. (2015) Structure of the TRPA1 ion channel suggests regulatory mechanisms, Nature, 520, 511–517.
12. Marsakova, L., Barvik, I., Zima, V., Zimova, L., and Vlachova, V. (2017) The first extracellular linker is important for several aspects of the gating mechanism of human TRPA1 channel, Front. Mol. Neurosci., 10, 16.
13. De la Roche, J., Eberhardt, M.J., Klinger, A.B., Stanslowsky, N., Wegner, F., Koppert, W., Reeh, P.W., Lampert, A., Fischer, M.J., and Leffler, A. (2013) The molecular basis for species-specific activation of human TRPA1 protein by protons involves poorly conserved residues within transmembrane domains 5 and 6, J. Biol. Chem., 288, 20280–20292.
14. Gonzalez-Ramirez, R., Chen, Y., Liedtke, W.B., and Morales-Lazaro, S.L. (2017) In TRP Channels and Pain (Emir T. L. R., ed), Boca Raton (FL), pp. 125–147.
15. Moran, M.M., and Szallasi, A. (2017) Targeting nociceptive transient receptor potential channels to treat chronic pain: сurrent state of the field, Br. J. Pharmacol., 175, 2185–2203.
16. Jardin, I., Lopez, J.J., Diez, R., Sanchez-Collado, J., Cantonero, C., Albarran, L., Woodard, G.E., Redondo, P.C., Salido, G.M., Smani, T., and Rosado, J.A. (2017) TRPs in pain sensation, Front. Physiol., 8, 392.
17. Shibasaki, K. (2016) Physiological significance of TRPV2 as a mechanosensor, thermosensor and lipid sensor, J. Physiol. Sci., 66, 359–365.
18. Broad, L., Mogg, A., Eberle, E., Tolley, M., Li, D., and Knopp, K. (2016) TRPV3 in drug development, Pharmaceuticals, 9, 55.
19. McNulty, A.L., Leddy, H.A., Liedtke, W., and Guilak, F. (2015) TRPV4 as a therapeutic target for joint diseases, Naunyn. Schmiedebergs. Arch. Pharmacol., 388, 437–450.
20. Sita, G., Hrelia, P., Graziosi, A., Ravegnini, G., and Morroni, F. (2018) TRPM2 in the brain: role in health and disease, Cells, 7, 82.
21. Matsumoto, K., Takagi, K., Kato, A., Ishibashi, T., Mori, Y., Tashima, K., Mitsumoto, A., Kato, S., and Horie, S. (2016) Role of transient receptor potential melastatin 2 (TRPM2) channels in visceral nociception and hypersensitivity, Exp. Neurol., 285, 41–50.
22. Thiel, G., Rubil, S., Lesch, A., Guethlein, L.A., and Rossler, O.G. (2017) Transient receptor potential TRPM3 channels: pharmacology, signaling, and biological functions, Pharmacol. Res., 124, 92–99.
23. Cabanas, H., Muraki, K., Eaton, N., Balinas, C., Staines, D., and Marshall-Gradisnik, S. (2018) Loss of transient receptor potential melastatin 3 ion channel function in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients, Mol. Med., 24, 44.
24. Naziroglu, M., and Braidy, N. (2017) Thermo-sensitive TRP channels: novel targets for treating chemotherapy-induced peripheral pain, Front. Physiol., 8, 1040.
25. Chen, J., and Hackos, D.H. (2015) TRPA1 as a drug target-promise and challenges, Naunyn. Schmiedebergs. Arch. Pharmacol., 388, 451–463.
26. Cordero-Morales, J.F., Gracheva, E.O., and Julius, D. (2011) Cytoplasmic ankyrin repeats of transient receptor potential A1 (TRPA1) dictate sensitivity to thermal and chemical stimuli, Proc. Natl. Acad. Sci. USA, 108, E1184–Е1191.
27. Wilso, S.R., Gerhold, K.A., Bifolck-Fisher, A., Liu, Q., Patel, K.N., Dong, X., and Bautista, D.M. (2011) TRPA1 is required for histamine-independent, mas-related G protein-coupled receptor-mediated itch, Nat. Neurosci., 14, 595–602.
28. Eberhardt, M.J., Filipovic, M.R., Leffler, A., de la Roche, J., Kistner, K., Fischer, M.J., Fleming, T., Zimmermann, K., Ivanovic-Burmazovic, I., Nawroth, P.P., Bierhaus, A., Reeh, P.W., and Sauer, S.K. (2012) Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): a possible mechanism of metabolic neuropathies, J. Biol. Chem., 287, 28291–28306.
29. Payandeh, J., Scheuer, T., Zheng, N., and Catterall, W.A. (2011) The crystal structure of a voltage-gated sodium channel, Nature, 475, 353–358.
30. Long, S.B., Campbell, E.B., and Mackinnon, R. (2005) Crystal structure of a mammalian voltage-dependent shaker family K+ channel, Science, 309, 897–903.
31. Susankova, K., Ettrich, R., Vyklicky, L., Teisinger, J., and Vlachova, V. (2007) Contribution of the putative inner-pore region to the gating of the transient receptor potential vanilloid subtype 1 channel (TRPV1), J. Neurosci., 27, 7578–7585.
32. Voets, T., Janssens, A., Droogmans, G., and Nilius, B. (2004) Outer pore architecture of a Ca2+-selective TRP channel, J. Biol. Chem., 279, 15223–15230.
33. Story, G.M., Peier, A.M., Reeve, A.J., Eid, S.R., Mosbacher, J., Hricik, T.R., Earley, T.J., Hergarden, A.C., Andersson, D.A., Hwang, S.W., McIntyre, P., Jegla, T., Bevan, S., and Patapoutian, A. (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures, Cell, 112, 819–829.
34. Knowlton, W.M., Bifolck-Fisher, A., Bautista, D.M., and McKemy, D.D. (2010) TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo, Pain, 150, 340–350.
35. Chen, J., Kang, D., Xu, J., Lake, M., Hogan, J.O., Sun, C., Walter, K., Yao, B., and Kim, D. (2013) Species differences and molecular determinant of TRPA1 cold sensitivity, Nat. Commun., 4, 2501.
36. Laursen, W.J., Anderson, E.O., Hoffstaetter, L.J., Bagriantsev, S.N., and Gracheva, E.O. (2015) Species-specific temperature sensitivity of TRPA1, Temperature, 2, 214–226.
37. Kang, K. (2016) Exceptionally high thermal sensitivity of rattlesnake TRPA1 correlates with peak current amplitude, Biochim. Biophys. Acta, 1858, 318–325.
38. Saito, S., Nakatsuka, K., Takahashi, K., Fukuta, N., Imagawa, T., Ohta, T., and Tominaga, M. (2012) Analysis of transient receptor potential ankyrin 1 (TRPA1) in frogs and lizards illuminates both nociceptive heat and chemical sensitivities and coexpression with TRP vanilloid 1 (TRPV1) in ancestral vertebrates, J. Biol. Chem., 287, 30743–30754.
39. Moparthi, L., Survery, S., Kreir, M., Simonsen, C., Kjellbom, P., Hogestatt, E.D., Johanson, U., and Zygmunt, P.M. (2014) Human TRPA1 is intrinsically cold- and chemosensitive with and without its N-terminal ankyrin repeat domain, Proc. Natl. Acad. Sci. USA, 111, 16901–16906.
40. Corey, D.P., Garcia-Anoveros, J., Holt, J.R., Kwan, K.Y., Lin, S.Y., Vollrath, M.A., Amalfitano, A., Cheung, E.L., Derfler, B.H., Duggan, A., Geleoc, G.S., Gray, P.A., Hoffman, M.P., Rehm, H.L., Tamasauskas, D., and Zhang, D.S. (2004) TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells, Nature, 432, 723–730.
41. Kerstein, P.C., del Camino, D., Moran, M.M., and Stucky, C.L. (2009) Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors, Mol. Pain, 5, 19.
42. Kwan, K.Y., Glazer, J.M., Corey, D.P., Rice, F.L., and Stucky, C.L. (2009) TRPA1 modulates mechanotransduction in cutaneous sensory neurons, J. Neurosci., 29, 4808–4819.
43. Brierley, S.M., Hughes, P.A., Page, A.J., Kwan, K.Y., Martin, C.M., O’Donnell, T.A., Cooper, N.J., Harrington, A.M., Adam, B., Liebregts, T., Holtmann, G., Corey, D.P., Rychkov, G.Y., and Blackshaw, L.A. (2009) The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli, Gastroenterology, 137, 2084–2095.
44. Lennertz, R.C., Kossyreva, E.A., Smith, A.K., and Stucky, C.L. (2012) TRPA1 mediates mechanical sensitization in nociceptors during inflammation, PLoS One, 7, e43597.
45. McGaraughty, S., Chu, K.L., Perner, R.J., Didomenico, S., Kort, M.E., and Kym, P.R. (2010) TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats, Mol. Pain, 6, 14.
46. Vilceanu, D., and Stucky, C.L. (2010) TRPA1 mediates mechanical currents in the plasma membrane of mouse sensory neurons, PLoS One, 5, e12177.
47. Hill, K., and Schaefer, M. (2007) TRPA1 is differentially modulated by the amphipathic molecules trinitrophenol and chlorpromazine, J. Biol. Chem., 282, 7145–7153.
48. Zhang, X.F., Chen, J., Faltynek, C.R., Moreland, R.B., and Neelands, T.R. (2008) Transient receptor potential A1 mediates an osmotically activated ion channel, Eur. J. Neurosci., 27, 605–611.
49. Meseguer, V., Alpizar, Y.A., Luis, E., Tajada, S., Denlinger, B., Fajardo, O., Manenschijn, J.A., Fernandez-Pena, C., Talavera, A., Kichko, T., Navia, B., Sanchez, A., Senaris, R., Reeh, P., Perez-Garcia, M.T., Lopez-Lopez, J.R., Voets, T., Belmonte, C., Talavera, K., and Viana, F. (2014) TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins, Nat. Commun., 5, 3125.
50. Bautista, D.M., Jordt, S.E., Nikai, T., Tsuruda, P.R., Read, A.J., Poblete, J., Yamoah, E.N., Basbaum, A.I., and Julius, D. (2006) TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents, Cell, 124, 1269–1282.
51. Petrus, M., Peier, A.M., Bandell, M., Hwang, S.W., Huynh, T., Olney, N., Jegla, T., and Patapoutian, A. (2007) A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition, Mol. Pain, 3, 40.
52. Andersson, D.A., Gentry, C., Light, E., Vastani, N., Vallortigara, J., Bierhaus, A., Fleming, T., and Bevan, S. (2013) Methylglyoxal evokes pain by stimulating TRPA1, PLoS One, 8, e77986.
53. Hinman, A., Chuang, H.H., Bautista, D.M., and Julius, D. (2006) TRP channel activation by reversible covalent modification, Proc. Natl. Acad. Sci. USA, 103, 19564–19568.
54. Macpherson, L.J., Geierstanger, B.H., Viswanath, V., Bandell, M., Eid, S.R., Hwang, S., and Patapoutian, A. (2005) The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin, Curr. Biol., 15, 929–934.
55. McKemy, D.D., Neuhausser, W.M., and Julius, D. (2002) Identification of a cold receptor reveals a general role for TRP channels in thermosensation, Nature, 416, 52–58.
56. Hu, H., Tian, J., Zhu, Y., Wang, C., Xiao, R., Herz, J.M., Wood, J.D., and Zhu, M.X. (2010) Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs, Pflugers. Arch., 459, 579–592.
57. Bandell, M., Story, G.M., Hwang, S.W., Viswanath, V., Eid, S.R., Petrus, M.J., Earley, T.J., and Patapoutian, A. (2004) Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin, Neuron, 41, 849–857.
58. Jordt, S.E., Bautista, D.M., Chuang, H.H., McKemy, D.D., Zygmunt, P.M., Hogestatt, E.D., Meng, I.D., and Julius, D. (2004) Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1, Nature, 427, 260–265.
59. Bautista, D.M., Movahed, P., Hinman, A., Axelsson, H.E., Sterner, O., Hogestatt, E.D., Julius, D., Jordt, S.E., and Zygmunt, P.M. (2005) Pungent products from garlic activate the sensory ion channel TRPA1, Proc. Natl. Acad. Sci. USA, 102, 12248–12252.
60. Koizumi, K., Iwasaki, Y., Narukawa, M., Iitsuka, Y., Fukao, T., Seki, T., Ariga, T., and Watanabe, T. (2009) Diallyl sulfides in garlic activate both TRPA1 and TRPV1, Biochem. Biophys. Res. Commun., 382, 545–548.
61. Bessac, B.F., Sivula, M., von Hehn, C.A., Caceres, A.I., Escalera, J., and Jordt, S.E. (2009) Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases, FASEB J., 23, 1102–1114.
62. Bessac, B.F., Sivula, M., von Hehn, C.A., Escalera, J., Cohn, L., and Jordt, S.E. (2008) TRPA1 is a major oxidant sensor in murine airway sensory neurons, J. Clin. Invest., 118, 1899–1910.
63. Sadofsky, L.R., Boa, A.N., Maher, S.A., Birrell, M.A., Belvisi, M.G., and Morice, A.H. (2011) TRPA1 is activated by direct addition of cysteine residues to the N-hydroxysuccinyl esters of acrylic and cinnamic acids, Pharmacol. Res., 63, 30–36.
64. Babes, A., Fischer, M.J., Filipovic, M., Engel, M.A., Flonta, M.L., and Reeh, P.W. (2013) The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel, Eur. J. Pharmacol., 704, 15–22.
65. Leffler, A., Lattrell, A., Kronewald, S., Niedermirtl, F., and Nau, C. (2011) Activation of TRPA1 by membrane permeable local anesthetics, Mol. Pain., 7, 62.
66. Zhong, J., Minassi, A., Prenen, J., Taglialatela-Scafati, O., Appendino, G., and Nilius, B. (2011) Umbellulone modulates TRP channels, Pflugers. Arch., 462, 861–870.
67. Nassini, R., Materazzi, S., Vriens, J., Prenen, J., Benemei, S., De Siena, G., la Marca, G., Andre, E., Preti, D., Avonto, C., Sadofsky, L., Di Marzo, V., De Petrocellis, L., Dussor, G., Porreca, F., Taglialatela-Scafati, O., Appendino, G., Nilius, B., and Geppetti, P. (2012) The «headache tree» via umbellulone and TRPA1 activates the trigeminovascular system, Brain, 135, 376–390.
68. Baraldi, P.G., Preti, D., Materazzi, S., and Geppetti, P. (2010) Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents, J. Med. Chem., 53, 5085–5107.
69. Macpherson, L.J., Dubin, A.E., Evans, M.J., Marr, F., Schultz, P.G., Cravatt, B.F., and Patapoutian, A. (2007) Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines, Nature, 445, 541–545.
70. Ibarra, Y., and Blair, N.T. (2013) Benzoquinone reveals a cysteine-dependent desensitization mechanism of TRPA1, Mol. Pharmacol., 83, 1120–1132.
71. Escalera, J., von Hehn, C.A., Bessac, B.F., Sivula, M., and Jordt, S.E. (2008) TRPA1 mediates the noxious effects of natural sesquiterpene deterrents, J. Biol. Chem., 283, 24136–24144.
72. Peyrot des Gachons, C., Uchida, K., Bryant, B., Shima, A., Sperry, J.B., Dankulich-Nagrudny, L., Tominaga, M., Smith, A.B., 3rd, Beauchamp, G.K., and Breslin, P.A. (2011) Unusual pungency from extra-virgin olive oil is attributable to restricted spatial expression of the receptor of oleocanthal, J. Neurosci., 31, 999–1009.
73. Riera, C.E., Menozzi-Smarrito, C., Affolter, M., Michlig, S., Munari, C., Robert, F., Vogel, H., Simon, S.A., and le Coutre, J. (2009) Compounds from Sichuan and Melegueta peppers activate, covalently and non-covalently, TRPA1 and TRPV1 channels, Br. J. Pharmacol., 157, 1398–1409.
74. Taylor-Clark, T.E., McAlexander, M.A., Nassenstein, C., Sheardown, S.A., Wilson, S., Thornton, J., Carr, M.J., and Undem, B.J. (2008) Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal, J. Physiol., 586, 3447–3459.
75. Trevisan, G., Hoffmeister, C., Rossato, M.F., Oliveira, S.M., Silva, M.A., Silva, C.R., Fusi, C., Tonello, R., Minocci, D., Guerra, G.P., Materazzi, S., Nassini, R., Geppetti, P., and Ferreira, J. (2014) TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute gout, Free. Radic. Biol. Med.,72, 200–209.
76. Andersson, D.A., Gentry, C., Moss, S., and Bevan, S. (2008) Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress, J. Neurosci., 28, 2485–2494.
77. Cruz-Orengo, L., Dhaka, A., Heuermann, R.J., Young, T.J., Montana, M.C., Cavanaugh, E.J., Kim, D., and Story, G.M. (2008) Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1, Mol. Pain, 4, 30.
78. Taylor-Clark, T.E., Nassenstein, C., McAlexander, M.A., and Undem, B.J. (2009) TRPA1: a potential target for antitussive therapy, Pulm. Pharmacol. Ther., 22, 71–74.
79. Motter, A.L., and Ahern, G.P. (2012) TRPA1 is a polyunsaturated fatty acid sensor in mammals, PLoS One, 7, e38439.
80. Takahashi, N., Mizuno, Y., Kozai, D., Yamamoto, S., Kiyonaka, S., Shibata, T., Uchida, K., and Mori, Y. (2008) Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators, Channels (Austin), 2, 287–298.
81. Matta, J.A., Cornett, P.M., Miyares, R.L., Abe, K., Sahibzada, N., and Ahern, G.P. (2008) General anesthetics activate a nociceptive ion channel to enhance pain and inflammation, Proc. Natl. Acad. Sci. USA, 105, 8784–8789.
82. Maher, M., Ao, H., Banke, T., Nasser, N., Wu, N.T., Breitenbucher, J.G., Chaplan, S.R., and Wickenden, A.D. (2008) Activation of TRPA1 by farnesyl thiosalicylic acid, Mol. Pharmacol., 73, 1225–1234.
83. Liu, K., Samuel, M., Ho, M., Harrison, R.K., and Paslay, J.W. (2010) NPPB structure-specifically activates TRPA1 channels, Biochem. Pharmacol., 80, 113–121.
84. Karashima, Y., Damann, N., Prenen, J., Talavera, K., Segal, A., Voets, T., and Nilius, B. (2007) Bimodal action of menthol on the transient receptor potential channel TRPA1, J. Neurosci., 27, 9874–9884.
85. Fischer, M.J., Leffler, A., Niedermirtl, F., Kistner, K., Eberhardt, M., Reeh, P.W., and Nau, C. (2010) The general anesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors, J. Biol. Chem., 285, 34781–34792.
86. Shintaku, K., Uchida, K., Suzuki, Y., Zhou, Y., Fushiki, T., Watanabe, T., Yazawa, S., and Tominaga, M. (2012) Activation of transient receptor potential A1 by a non-pungent capsaicin-like compound, capsiate, Br. J. Pharmacol., 165, 1476–1486.
87. Andersson, D.A., Gentry, C., and Bevan, S. (2012) TRPA1 has a key role in the somatic pro-nociceptive actions of hydrogen sulfide, PLoS One, 7, e46917.
88. Eberhardt, M., Dux, M., Namer, B., Miljkovic, J., Cordasic, N., Will, C., Kichko, T.I., de la Roche, J., Fischer, M., Suarez, S.A., Bikiel, D., Dorsch, K., Leffler, A., Babes, A., Lampert, A., Lennerz, J.K., Jacobi, J., Marti, M.A., Doctorovich, F., Hogestatt, E.D., Zygmunt, P.M., Ivanovic-Burmazovic, I., Messlinger, K., Reeh, P., and Filipovic, M.R. (2014) H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway, Nat. Commun., 5, 4381.
89. Takahashi, N., Kuwaki, T., Kiyonaka, S., Numata, T., Kozai, D., Mizuno, Y., Yamamoto, S., Naito, S., Knevels, E., Carmeliet, P., Oga, T., Kaneko, S., Suga, S., Nokami, T., Yoshida, J., and Mori, Y. (2011) TRPA1 underlies a sensing mechanism for O2, Nat. Chem. Biol., 7, 701–711.
90. Hu, H., Bandell, M., Petrus, M.J., Zhu, M.X., and Patapoutian, A. (2009) Zinc activates damage-sensing TRPA1 ion channels, Nat. Chem. Biol., 5, 183–190.
91. Wang, Y.Y., Chang, R.B., Waters, H.N., McKemy, D.D., and Liman, E.R. (2008) The nociceptor ion channel TRPA1 is potentiated and inactivated by permeating calcium ions, J. Biol. Chem., 283, 32691–32703.
92. Zurborg, S., Yurgionas, B., Jira, J.A., Caspani, O., and Heppenstall, P.A. (2007) Direct activation of the ion channel TRPA1 by Ca2+, Nat. Neurosci., 10, 277–279.
93. Hasan, R., Leeson-Payne, A.T.S., Jaggar, J.H., and Zhang, X. (2017) Calmodulin is responsible for Ca2+-dependent regulation of TRPA1 Channels, Sci. Rep., 7, 45098.
94. Talavera, K., Gees, M., Karashima, Y., Meseguer, V.M., Vanoirbeek, J.A., Damann, N., Everaerts, W., Benoit, M., Janssens, A., Vennekens, R., Viana, F., Nemery, B., Nilius, B., and Voets, T. (2009) Nicotine activates the chemosensory cation channel TRPA1, Nat. Neurosci., 12, 1293–1299.
95. Alpizar, Y.A., Gees, M., Sanchez, A., Apetrei, A., Voets, T., Nilius, B., and Talavera, K. (2013) Bimodal effects of cinnamaldehyde and camphor on mouse TRPA1, Pflugers. Arch., 465, 853–864.
96. Cavanaugh, E.J., Simkin, D., and Kim, D. (2008) Activation of transient receptor potential A1 channels by mustard oil, tetrahydrocannabinol and Ca2+ reveals different functional channel states, Neuroscience, 154, 1467–1476.
97. Nagatomo, K., and Kubo, Y. (2008) Caffeine activates mouse TRPA1 channels but suppresses human TRPA1 channels, Proc. Natl. Acad. Sci. USA, 105, 17373–17378.
98. Nagatomo, K., Ishii, H., Yamamoto, T., Nakajo, K., and Kubo, Y. (2010) The Met268Pro mutation of mouse TRPA1 changes the effect of caffeine from activation to suppression, Biophys. J., 99, 3609–3618.
99. Takaishi, M., Uchida, K., Fujita, F., and Tominaga, M. (2014) Inhibitory effects of monoterpenes on human TRPA1 and the structural basis of their activity, J. Physiol. Sci., 64, 47–57.
100. Takaishi, M., Fujita, F., Uchida, K., Yamamoto, S., Sawada Shimizu, M., Hatai Uotsu, C., Shimizu, M., and Tominaga, M. (2012) 1,8-cineole, a TRPM8 agonist, is a novel natural antagonist of human TRPA1, Mol. Pain, 8, 86.
101. Wang, S., Zhai, C., Zhang, Y., Yu, Y., Zhang, Y., Lianghui, M., Li, S., and Qiao, Y. (2016) Cardamonin, a novel antagonist of hTRPA1 cation channel, reveals therapeutic mechanism of pathological pain, Molecules, 21, E1145.
102. McNamara, C.R., Mandel-Brehm, J., Bautista, D.M., Siemens, J., Deranian, K.L., Zhao, M., Hayward, N.J., Chong, J.A., Julius, D., Moran, M.M., and Fanger, C.M. (2007) TRPA1 mediates formalin-induced pain, Proc. Natl. Acad. Sci. USA, 104, 13525–13530.
103. Eid, S.R., Crown, E.D., Moore, E.L., Liang, H.A., Choong, K.C., Dima, S., Henze, D.A., Kane, S.A., and Urban, M.O. (2008) HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity, Mol. Pain, 4, 48.
104. Wei, H., Hamalainen, M.M., Saarnilehto, M., Koivisto, A., and Pertovaara, A. (2009) Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals, Anesthesiology, 111, 147–154.
105. Schenkel, L.B., Olivieri, P.R., Boezio, A.A., Deak, H.L., Emkey, R., Graceffa, R.F., Gunaydin, H., Guzman-Perez, A., Lee, J.H., Teffera, Y., Wang, W., Youngblood, B.D., Yu, V.L., Zhang, M., Gavva, N.R., Lehto, S.G., and Geuns-Meyer, S. (2016) Optimization of a novel quinazolinone-based series of transient receptor potential A1 (TRPA1) antagonists demonstrating potent in vivo activity, J. Med. Chem., 59, 2794–2809.
106. Gijsen, H.J.M., Berthelot, D., De Cleyn, M.A.J., Geuens, I., Brone, B., and Mercken, M. (2012) Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists, Bioorg. Med. Chem. Lett., 22, 797–800.
107. Bhattacharya, A., Eckert, W., Ao, H., Lebsack, A., Rech, J., and Wickenden, A. (2014) The effect of a novel TRPA1 antagonist JNJ-41477670 on models of airway hyperactivity and inflammation in rats, FASEB J., 28, 660.6.
108. Chen, J., Joshi, S.K., DiDomenico, S., Perner, R.J., Mikusa, J.P., Gauvin, D.M., Segreti, J.A., Han, P., Zhang, X.F., Niforatos, W., Bianchi, B.R., Baker, S.J., Zhong, C., Simler, G.H., McDonald, H.A., Schmidt, R.G., McGaraughty, S.P., Chu, K.L., Faltynek, C.R., Kort, M.E., Reilly, R.M., and Kym, P.R. (2011) Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation, Pain, 152, 1165–1172.
109. Defalco, J., Steiger, D., Gustafson, A., Emerling, D.E., Kelly, M.G., and Duncton, M.A. (2010) Oxime derivatives related to AP18: agonists and antagonists of the TRPA1 receptor, Bioorg. Med. Chem. Lett., 20, 276–279.
110. Nyman, E., Franzen, B., Nolting, A., Klement, G., Liu, G., Nilsson, M., Rosen, A., Bjork, C., Weigelt, D., Wollberg, P., Karila, P., and Raboisson, P. (2013) In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model, J. Pain Res., 6, 59–70.
111. Laliberte, S., Vallee, F., Fournier, P.A., Bedard, L., Labrecque, J., and Albert, J.S. (2014) Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)-benzamides as TRPA1 antagonists, Bioorg. Med. Chem. Lett., 24, 3204–3206.
112. Pryde, D.C., Marron, B., West, C.G., Reister, S., Amato, G., Yoger, K., Padilla, K., Turner, J., Swain, N.A., Cox, P.J., Skerratt, S.E., Ryckmans, T., Blakemore, D.C., Warmus, J., and Gerlach, A.C. (2016) The discovery of a potent series of carboxamide TRPA1 antagonists, Med. Chem. Commun., 7, 2145–2158.
113. Kanju, P., Chen, Y., Lee, W., Yeo, M., Lee, S.H., Romac, J., Shahid, R., Fan, P., Gooden, D.M., Simon, S.A., Spasojevic, I., Mook, R.A., Liddle, R.A., Guilak, F., and Liedtke, W.B. (2016) Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain, Sci. Rep., 6, 26894.
114. Caceres, A.I., Brackmann, M., Elia, M.D., Bessac, B.F., del Camino, D., D’Amours, M., Witek, J.S., Fanger, C.M., Chong, J.A., Hayward, N.J., Homer, R.J., Cohn, L., Huang, X., Moran, M.M., and Jordt, S.E. (2009) A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma, Proc. Natl. Acad. Sci. USA, 106, 9099–9104.
115. Skerratt, S. (2017) Recent progress in the discovery and development of TRPA1 modulators, Prog. Med. Chem., 56, 81–115.
116. Gui, J., Liu, B., Cao, G., Lipchik, A.M., Perez, M., Dekan, Z., Mobli, M., Daly, N.L., Alewood, P.F., Parker, L.L., King, G.F., Zhou, Y., Jordt, S.E., and Nitabach, M.N. (2014) A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1–S4 gating domain, Curr. Biol., 24, 473–483.
117. Tonello, R., Fusi, C., Materazzi, S., Marone, I.M., De Logu, F., Benemei, S., Goncalves, M.C., Coppi, E., Castro-Junior, C.J., Gomez, M.V., Geppetti, P., Ferreira, J., and Nassini, R. (2017) The peptide Phб1в, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice, Br. J. Pharmacol., 174, 57–69.
118. De Souza, A.H., Lima, M.C., Drewes, C.C., da Silva, J.F., Torres, K.C.L., Pereira, E.M.R., de Castro, C.J., Vieira, L.B., Cordeiro, M.N., Richardson, M., Gomez, R.S., Romano-Silva, M.A., Ferreira, J., and Gomez, M.V. (2011) Antiallodynic effect and side effects of Phα1β, a neurotoxin from the spider Phoneutria nigriventer: Comparison with ω-conotoxin MVIIA and morphine, Toxicon, 58, 626–633.
119. Logashina, Y.A., Mosharova, I.V., Korolkova, Y.V., Shelukhina, I.V., Dyachenko, I.A., Palikov, V.A., Palikova, Y.A., Murashev, A.N., Kozlov, S.A., Stensvag, K., and Andreev, Y.A. (2017) Peptide from sea anemone metridium senile affects transient receptor potential ankyrin-repeat 1 (TRPA1) function and produces analgesic effect, J. Biol. Chem., 292, 2992–3004.
120. Logashina, Y.A., Solstad, R.G., Mineev, K.S., Korolkova, Y.V., Mosharova, I.V., Dyachenko, I.A., Palikov, V.A., Palikova, Y.A., Murashev, A.N., Arseniev, A.S., Kozlov, S.A., Stensvag, K., Haug, T., and Andreev, Y.A. (2017) New disulfide-stabilized fold provides sea anemone peptide to exhibit both antimicrobial and TRPA1 potentiating properties, Toxins (Basel), 9, E154.
121. Koltzenburg, M., Lundberg, L.E., and Torebjork, H.E. (1992) Dynamic and static components of mechanical hyperalgesia in human hairy skin, Pain, 51, 207–219.
122. Namer, B., Seifert, F., Handwerker, H.O., and Maihofner, C. (2005) TRPA1 and TRPM8 activation in humans: effects of cinnamaldehyde and menthol, Neuroreport, 16, 955–959.
123. Olausson, B. (1998) Recordings of human polymodal single C-fiber afferents following mechanical and argon-laser heat stimulation of inflamed skin, Exp. Brain Res., 122, 55–61.
124. Cevikbas, F., Wang, X., Akiyama, T., Kempkes, C., Savinko, T., Antal, A., Kukova, G., Buhl, T., Ikoma, A., Buddenkotte, J., Soumelis, V., Feld, M., Alenius, H., Dillon, S.R., Carstens, E., Homey, B., Basbaum, A., and Steinhoff, M. (2014) A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1, J. Allergy Clin. Immunol., 133, 448–460.
125. Liu, B., Escalera, J., Balakrishna, S., Fan, L., Caceres, A.I., Robinson, E., Sui, A., McKay, M.C., McAlexander, M.A., Herrick, C.A., and Jordt, S.E. (2013) TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis, FASEB J., 27, 3549–3563.
126. Oh, M.H., Oh, S.Y., Lu, J., Lou, H., Myers, A.C., Zhu, Z., and Zheng, T. (2013) TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis, J. Immunol., 191, 5371–5382.
127. Wilson, S.R., Nelson, A.M., Batia, L., Morita, T., Estandian, D., Owens, D.M., Lumpkin, E.A., and Bautista, D.M. (2013) The ion channel TRPA1 is required for chronic itch, J. Neurosci., 33, 9283–9294.
128. Andre, E., Campi, B., Materazzi, S., Trevisani, M., Amadesi, S., Massi, D., Creminon, C., Vaksman, N., Nassini, R., Civelli, M., Baraldi, P.G., Poole, D.P., Bunnett, N.W., Geppetti, P., and Patacchini, R. (2008) Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents, J. Clin. Invest., 118, 2574–2582.
129. Dolovich, J., Back, N., and Arbesman, C.E. (1970) Kinin-like activity in nasal secretions of allergic patients, Int. Arch. Allergy Appl. Immunol., 38, 337–344.
130. Winterbourn, C.C., and Kettle, A.J. (2000) Biomarkers of myeloperoxidase-derived hypochlorous acid, Free Radic. Biol. Med., 29, 403–409.
131. Kaji, I., Yasuoka, Y., Karaki, S., and Kuwahara, A. (2012) Activation of TRPA1 by luminal stimuli induces EP4-mediated anion secretion in human and rat colon, Am. J. Physiol. Gastrointest. Liver Physiol., 302, G690–701.
132. Penuelas, A., Tashima, K., Tsuchiya, S., Matsumoto, K., Nakamura, T., Horie, S., and Yano, S. (2007) Contractile effect of TRPA1 receptor agonists in the isolated mouse intestine, Eur. J. Pharmacol., 576, 143–150.
133. Howard, J., and Bechstedt, S. (2004) Hypothesis: a helix of ankyrin repeats of the NOMPC-TRP ion channel is the gating spring of mechanoreceptors, Curr. Biol., 14, R224-6.
134. Engel, M.A., Khalil, M., Mueller-Tribbensee, S.M., Becker, C., Neuhuber, W.L., Neurath, M.F., and Reeh, P.W. (2012) The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons, J. Gastroenterol., 47, 256–265.
135. Engel, M.A., Leffler, A., Niedermirtl, F., Babes, A., Zimmermann, K., Filipovic, M.R., Izydorczyk, I., Eberhardt, M., Kichko, T.I., Mueller-Tribbensee, S.M., Khalil, M., Siklosi, N., Nau, C., Ivanovic-Burmazovic, I., Neuhuber, W.L., Becker, C., Neurath, M.F., and Reeh, P.W. (2011) TRPA1 and substance P mediate colitis in mice, Gastroenterology, 141, 1346–1358.
136. Schwartz, E.S., La, J.H., Scheff, N.N., Davis, B.M., Albers, K.M., and Gebhart, G.F. (2013) TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis, J. Neurosci., 33, 5603–5611.
137. Meotti, F.C., Forner, S., Lima-Garcia, J.F., Viana, A.F., and Calixto, J.B. (2013) Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis, Chem. Biol. Interact., 203, 440–447.
138. Obata, K., Katsura, H., Mizushima, T., Yamanaka, H., Kobayashi, K., Dai, Y., Fukuoka, T., Tokunaga, A., Tominaga, M., and Noguchi, K. (2005) TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury, J. Clin. Invest., 115, 2393–2401.
139. Lozano-Ondoua, A.N., Symons-Liguori, A.M., and Vanderah, T.W. (2013) Cancer-induced bone pain: mechanisms and models, Neurosci. Lett., 557, 52–59.
140. Ye, Y., Dang, D., Zhang, J., Viet, C.T., Lam, D.K., Dolan, J.C., Gibbs, J.L., and Schmidt, B.L. (2011) Nerve growth factor links oral cancer progression, pain, and cachexia, Mol. Cancer Ther., 10, 1667–1676.
141. Lee, S.M., Cho, Y.S., Kim, T.H., Jin, M.U., Ahn, D.K., Noguchi, K., and Bae, Y.C. (2012) An ultrastructural evidence for the expression of transient receptor potential ankyrin 1 (TRPA1) in astrocytes in the rat trigeminal caudal nucleus, J. Chem. Neuroanat., 45, 45–49.
142. Shigetomi, E., Jackson-Weaver, O., Huckstepp, R.T., O’Dell, T.J., and Khakh, B.S. (2013) TRPA1 channels are regulators of astrocyte basal calcium levels and long-term potentiation via constitutive D-serine release, J. Neurosci., 33, 10143–10153.
143. Shigetomi, E., Tong, X., Kwan, K.Y., Corey, D.P., and Khakh, B.S. (2012) TRPA1 channels regulate astrocyte resting calcium and inhibitory synapse efficacy through GAT-3, Nat. Neurosci., 15, 70–80.
144. Vennekens, R., Menigoz, A., and Nilius, B. (2012) TRPs in the brain, Rev. Physiol. Biochem. Pharmacol., 163, 27–64.
145. Due, M.R., Park, J., Zheng, L., Walls, M., Allette, Y.M., White, F.A., and Shi, R. (2014) Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat, J. Neurochem., 128, 776–786.
146. Gregus, A.M., Doolen, S., Dumlao, D.S., Buczynski, M.W., Takasusuki, T., Fitzsimmons, B.L., Hua, X.Y., Taylor, B.K., Dennis, E.A., and Yaksh, T.L. (2012) Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors, Proc. Natl. Acad. Sci. USA, 109, 6721–6726.
147. Lee, I., Kim, H.K., Kim, J.H., Chung, K., and Chung, J.M. (2007) The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons, Pain, 133, 9–17.
148. Sisignano, M., Park, C.K., Angioni, C., Zhang, D.D., von Hehn, C., Cobos, E.J., Ghasemlou, N., Xu, Z.Z., Kumaran, V., Lu, R., Grant, A., Fischer, M.J., Schmidtko, A., Reeh, P., Ji, R.R., Woolf, C.J., Geisslinger, G., Scholich, K., and Brenneis, C. (2012) 5,6-EET is released upon neuronal activity and induces mechanical pain hypersensitivity via TRPA1 on central afferent terminals, J. Neurosci., 32, 6364–6372.
149. Wei, H., Chapman, H., Saarnilehto, M., Kuokkanen, K., Koivisto, A., and Pertovaara, A. (2010) Roles of cutaneous versus spinal TRPA1 channels in mechanical hypersensitivity in the diabetic or mustard oil-treated non-diabetic rat, Neuropharmacology, 58, 578–584.
150. Da Costa, D.S., Meotti, F.C., Andrade, E.L., Leal, P.C., Motta, E.M., and Calixto, J.B. (2010) The involvement of the transient receptor potential A1 (TRPA1) in the maintenance of mechanical and cold hyperalgesia in persistent inflammation, Pain, 148, 431–437.
151. Xing, J., Lu, J., and Li, J. (2015) TRPA1 mediates amplified sympathetic responsiveness to activation of metabolically sensitive muscle afferents in rats with femoral artery occlusion, Front. Physiol., 6, 249.
152. Hamilton, N.B., Kolodziejczyk, K., Kougioumtzidou, E., and Attwell, D. (2016) Proton-gated Ca2+-permeable TRP channels damage myelin in conditions mimicking ischaemia, Nature, 529, 523–527.
153. Gough, N.R. (2016) Toxic TRPA1 activity degrades myelin, Sci. Signal., 351, 641–782.
154. Materazzi, S., Benemei, S., Fusi, C., Gualdani, R., De Siena, G., Vastani, N., Andersson, D.A., Trevisan, G., Moncelli, M.R., Wei, X., Dussor, G., Pollastro, F., Patacchini, R., Appendino, G., Geppetti, P., and Nassini, R. (2013) Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel, Pain, 154, 2750–2758.
155. Horvath, A., Tekus, V., Boros, M., Pozsgai, G., Botz, B., Borbely, E., Szolcsanyi, J., Pinter, E., and Helyes, Z. (2016) Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice, Arthritis Res. Ther., 18, 6.
156. Moran, M.M., McAlexander, M.A., Biro, T., and Szallasi, A. (2011) Transient receptor potential channels as therapeutic targets, Nat. Rev. Drug Discov., 10, 601–620.
157. Koivisto, A., Hukkanen, M., Saarnilehto, M., Chapman, H., Kuokkanen, K., Wei, H., Viisanen, H., Akerman, K.E., Lindstedt, K., and Pertovaara, A. (2012) Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy, Pharmacol. Res., 65, 149–158.
158. Kremeyer, B., Lopera, F., Cox, J.J., Momin, A., Rugiero, F., Marsh, S., Woods, C.G., Jones, N.G., Paterson, K.J., Fricker, F.R., Villegas, A., Acosta, N., Pineda-Trujillo, N.G., Ramirez, J.D., Zea, J., Burley, M.W., Bedoya, G., Bennett, D.L., Wood, J.N., and Ruiz-Linares, A. (2010) A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome, Neuron, 66, 671–680.
159. Binder, A., May, D., Baron, R., Maier, C., Tolle, T.R., Treede, R.D., Berthele, A., Faltraco, F., Flor, H., Gierthmuhlen, J., Haenisch, S., Huge, V., Magerl, W., Maihofner, C., Richter, H., Rolke, R., Scherens, A., Uceyler, N., Ufer, M., Wasner, G., Zhu, J., and Cascorbi, I. (2011) Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients, PLoS One, 6, e17387.
160. May, D., Baastrup, J., Nientit, M.R., Binder, A., Schunke, M., Baron, R., and Cascorbi, I. (2012) Differential expression and functionality of TRPA1 protein genetic variants in conditions of thermal stimulation, J. Biol. Chem., 287, 27087–27094.
161. Gouin, O., L’Herondelle, K., Lebonvallet, N., Le Gall-Ianotto, C., Sakka, M., Buhe, V., Plee-Gautier, E., Carre, J.-L., Lefeuvre, L., Misery, L., and Le Garrec, R. (2017) TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization, Protein Cell, 8, 644-661.
162. Lee, L.-Y., Hsu, C.-C., Lin, Y.-J., Lin, R.-L., and Khosravi, M. (2015) Interaction between TRPA1 and TRPV1: synergy on pulmonary sensory nerves, Pulm. Pharmacol. Ther., 35, 87–93.
163. Spahn, V., Stein, C., and Zollner, C. (2014) Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1, Mol. Pharmacol., 85, 335–344.
164. Andrade, E.L., Meotti, F.C., and Calixto, J.B. (2012) TRPA1 antagonists as potential analgesic drugs, Pharmacol. Ther., 133, 189–204.
165. Mukhopadhyay, I., Kulkarni, A., Aranake, S., Karnik, P., Shetty, M., Thorat, S., Ghosh, I., Wale, D., Bhosale, V., and Khairatkar-Joshi, N. (2014) Transient receptor potential ankyrin 1 receptor activation in vitro and in vivo by protussive agents: GRC 17536 as a promising anti-tussive therapeutic, PLoS One, 9, e97005.
166. Ramanathan, B., Viswanathan, V., Jali, M.V., Jain, S.M., Dhanwal, D., Srikanta, S., Shembalkar, J., Dewland, P., Forst, T., Shammana, P., Asirvatham, A., Magdum, M., Lubenova, B., and Dolezil, D. (2014) A clinical trial to study the effects GRC 17536 in patients with painful diabetic peripheral neuropathy (painful extremities due to peripheral nerve damage in diabetic patients), Clin. Trials. Gov., NCT01726413.
167. Weng, Y., Batista-Schepman, P.A., Barabas, M.E., Harris, E.Q., Dinsmore, T.B., Kossyreva, E.A., Foshage, A.M., Wang, M.H., Schwab, M.J., Wang, V.M., Stucky, C.L., and Story, G.M. (2012) Prostaglandin metabolite induces inhibition of TRPA1 and channel-dependent nociception, Mol. Pain, 8, 75.
168. Kojima, R., Nozawa, K., Doihara, H., Keto, Y., Kaku, H., Yokoyama, T., and Itou, H. (2014) Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain, Eur. J. Pharmacol., 723, 288–293.
169. Andersson, D.A., Gentry, C., Alenmyr, L., Killander, D., Lewis, S.E., Andersson, A., Bucher, B., Galzi, J.L., Sterner, O., Bevan, S., Hogestatt, E.D., and Zygmunt, P.M. (2011) TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol, Nat. Commun., 2, 551.